Effects of Glycemic Variability on Regulatory T Cells in Patients with Type 2 Diabetes and Kidney Disease

被引:1
|
作者
Gu, Qing-Wei [1 ]
Sun, Qi [1 ]
Wang, Jie [1 ]
Gu, Wen-Sha [1 ]
Wang, Wei [1 ]
Mao, Xiao-Ming [1 ]
机构
[1] Nanjing Med Univ, Nanjing Hosp 1, Dept Endocrinol, 68 ChangLe St, Nanjing 210006, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
type 2 diabetes mellitus; diabetic kidney disease; glycemic variability; regulatory T cells; inflammatory cytokines; INFLAMMATION; NEPHROPATHY; MECHANISMS; PATHOGENESIS; RISK;
D O I
10.2147/DMSO.S413407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To investigate the pathogenesis of diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM), we evaluated the effects of short-term glycemic variability (GV) on the profile of T cell subpopulations.Methods: A total of 47 T2DM patients with normoalbuminuria, 47 microalbuminuria, and 49 macroalbuminuria were enrolled. The continuous glucose monitoring (CGM) determined the GV of enrolled patients. Flow cytometry was used to determine the proportion of T cell subpopulations.Results: The frequency of T helper (Th) 17 and Th1 cells significantly increased while regulatory T cells (Tregs) significantly decreased in the macroalbuminuria group compared to normoalbuminuria and microalbuminuria groups (P < 0.01). The suppressive function of Tregs was significantly lower in the macroalbuminuria group than the normoalbuminuria group (P < 0.05). Compared with the normoalbuminuria group, the mean amplitude of glucose excursions (MAGE) of the macroalbuminuria group was significantly higher (P<0.05). Furthermore, there were negative associations between the proportion of Tregs and MAGE.Conclusions: Increased GV could decrease the proportion of Tregs and may impair their function. This may lead to increases in Th1 and Th17 cells, and some inflammatory cytokines, which might contribute to the development and progression of DKD in T2DM.
引用
收藏
页码:2365 / 2375
页数:11
相关论文
共 50 条
  • [21] Cholesterol and glycemic effects of Niaspan in patients with type 2 diabetes
    Kane, MR
    Hamilton, RA
    Addesse, E
    Busch, RS
    Bakst, G
    PHARMACOTHERAPY, 2001, 21 (12): : 1473 - 1478
  • [22] PROGNOSTIC VALUE OF GLYCEMIC VARIABILITY IN SURGICAL PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Strongin, L.
    Beliaeva, N.
    Komissarova, E.
    Tezyaeva, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A136 - A136
  • [23] Insulin Injection Technique is Associated with Glycemic Variability in Patients with Type 2 Diabetes
    Lu Yuan
    Fengfei Li
    Ting Jing
    Bo Ding
    Yong Luo
    Rui Sun
    Xiuping Wang
    Hefeng Diao
    Xiaofei Su
    Lei Ye
    Jianhua Ma
    Diabetes Therapy, 2018, 9 : 2347 - 2356
  • [24] Insulin Injection Technique is Associated with Glycemic Variability in Patients with Type 2 Diabetes
    Yuan, Lu
    Li, Fengfei
    Jing, Ting
    Ding, Bo
    Luo, Yong
    Sun, Rui
    Wang, Xiuping
    Diao, Hefeng
    Su, Xiaofei
    Ye, Lei
    Ma, Jianhua
    DIABETES THERAPY, 2018, 9 (06) : 2347 - 2356
  • [25] Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus
    Werzowa, Johannes
    Pacini, Giovanni
    Hecking, Manfred
    Fidler, Catharina
    Haidinger, Michael
    Brath, Helmut
    Thomas, Andreas
    Saeemann, Marcus D.
    Tura, Andrea
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1211 - 1216
  • [26] The pharmacogenetics of hypoglycemia and the glycemic variability at the patients ith type 2 diabetes mellitus
    Chernikova, N. A.
    Kamynina, L. L.
    Ametov, A. S.
    Sychev, D. A.
    Grishina, E. A.
    Ryzhikova, K. A.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (10) : 54 - 62
  • [27] Impact of glycemic variability on the levels of endothelial progenitor cells in patients with type 1 diabetes
    Inaba Y.
    Tsutsumi C.
    Haseda F.
    Fujisawa R.
    Mitsui S.
    Sano H.
    Terasaki J.
    Hanafusa T.
    Imagawa A.
    Diabetology International, 2018, 9 (2) : 113 - 120
  • [28] Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
    Rattik, Sara
    Engelbertsen, Daniel
    Wigren, Maria
    Ljungcrantz, Irena
    Ostling, Gerd
    Persson, Margaretha
    Nordin Fredrikson, Gunilla
    Bengtsson, Eva
    Nilsson, Jan
    Bjorkbacka, Harry
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (03): : 270 - 280
  • [29] A Diabetes-Specific Enteral Formula Improves Glycemic Variability in Patients with Type 2 Diabetes
    Alish, Carolyn J.
    Garvey, W. Timothy
    Maki, Kevin C.
    Sacks, Gordon S.
    Hustead, Deborah S.
    Hegazi, Refaat A.
    Mustad, Vikkie A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (06) : 419 - 425
  • [30] The Impact of Glycemic Variability on CAN in Patients with Type 1 Diabetes
    Jaiswal, Mamta
    Plunkett, Cynthia
    Henderson, James
    Comment, Nicholas
    Nelson, Patrick
    Pop-Busui, Rodica
    Feldman, Eva L.
    ANNALS OF NEUROLOGY, 2013, 74 : S99 - S99